Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
40.90
0.00 (0.00%)
At close: Dec 23, 2025
-13.44%
Market Cap750.74M
Revenue (ttm)373.90M
Net Income (ttm)-2.89M
Shares Out18.36M
EPS (ttm)-0.16
PE Ration/a
Forward PE47.01
Dividendn/a
Ex-Dividend Daten/a
Volume96,971
Average Volume30,495
Open40.60
Previous Closen/a
Day's Range40.30 - 41.20
52-Week Range26.50 - 53.00
Beta0.03
RSI38.82
Earnings DateMar 27, 2026

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.